Brief: Mendus Receives ATMP Certificate From European Medicines Agency

Mendus AB (publ)

19/06/2023 07:34

June 19 (Reuters) - Mendus AB (publ)  IMMUN.ST :
    * REG-MENDUS RECEIVES ATMP CERTIFICATE FROM EUROPEAN
MEDICINES
AGENCY SUPPORTING ITS LEAD PIPELINE PROGRAM VIDIDENCEL
    * EXPECTS TO PRESENT A NEXT SURVIVAL READ-OUT OF ADVANCE II
TRIAL
IN Q4 OF 2023.

Source text for Eikon:  ID:nGNEtM8bx 
Further company coverage:  IMMUN.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))